My admittedly limited understanding of the clinical trial process is that there isn’t that much that RH and the top team can do once it’s kicked off. It’s in the hands of the physicians running the trial and you hope that it’s been designed well and wait for the results.
so I don’t see a this AI initiative as a major distraction, rather I see it as a relatively low cost investment that may pay off big in the future. If it doesn’t, I don’t think much is lost
My admittedly limited understanding of the clinical trial...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.050(4.17%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.20 | $1.15 | $146.7K | 125.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71742 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 11949 | 2 |
View Market Depth
| Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |